Metraipolis › archive › dc_778bc1b36ed3
Efficacy and mechanisms of immune checkpoint inhibitors in late-stage EGFR-mutated non-small cell lung cancer following targeted therapy resistance — Europe PMC PMID:42317338
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42317338
- DOI
- 10.3389/fimmu.2026.1845547
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-31T18:57:05.440Z
- SHA-256 of the archived text
45e2d0b257963fa8a33f749d329ea6f8c6dd4c057229cc97c017758da257459f- Stable URL of this page
https://metraipolis.com/documento/dc_778bc1b36ed3
How to cite
Efficacy and mechanisms of immune checkpoint inhibitors in late-stage EGFR-mutated non-small cell lung cancer following targeted therapy resistance — Europe PMC PMID:42317338 — Europe PMC (en), https://europepmc.org/article/MED/42317338 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_778bc1b36ed3 (Metraipolis archive dc_778bc1b36ed3, sha256 45e2d0b257963fa8a33f749d329ea6f8c6dd4c057229cc97c017758da257459f)
BibTeX
@misc{dc778bc1b36ed3,
title = {Efficacy and mechanisms of immune checkpoint inhibitors in late-stage EGFR-mutated non-small cell lung cancer following targeted therapy resistance — Europe PMC PMID:42317338},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42317338},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_778bc1b36ed3; sha256 45e2d0b257963fa8a33f749d329ea6f8c6dd4c057229cc97c017758da257459f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42317338. Agents can read the archived copy with the MCP tool read_document.